IL6 and COVID-19: Interestingly, a potential relationship between the cytokine IL-6, which is overrepresented in COVID-19 patients [22], and reactivation of HSV has been proposed [23]. Compared to mice receiving control antibodies, HSV-latently infected mice injected with neutralizing anti-IL-6 antibodies show a lower frequency of virus reactivation [24].